研究者

J-GLOBAL ID：200901021239585804 更新日: 2024年12月18日

遠藤高志

エンドウタカシ | Endou Takashi

所属機関・部署：
職名：助教
MISC (26件)：

T Yamauchi, M Watanabe, H Hasegawa, S Yamamoto, T Endo, Y Kabeshima, K Yorozuya, K Yamamoto, M Kitajima. Serrated adenoma developing into advanced colon cancer in 2 years. JOURNAL OF GASTROENTEROLOGY. 2002. 37. 6. 467-470
T Endo, M Toda, M Watanabe, Y Iizuka, T Kubota, M Kitajima, Y Kawakami. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer. CANCER GENE THERAPY. 2002. 9. 2. 142-148
Narai Shin, Watanabe Masahiko, Hasegawa Hirotoshi, Nishibori Hideki, Endo Takashi, Kubota Tetsuro, Kitajima Masaki. Significance of transforming growth factor β1 as a new tumor marker for colorectal cancer. International journal of cancer. 2002. 97. 4. 508-511
S Narai, M Watanabe, H Hasegawa, H Nishibori, T Endo, T Kubota, M Kitajima. Significance of transforming growth factor beta 1 as a new tumor marker for colorectal cancer. INTERNATIONAL JOURNAL OF CANCER. 2002. 97. 4. 508-511
T Yamauchi, M Watanabe, T Kubota, H Hasegawa, Y Ishii, T Endo, Y Kabeshima, K Yorozuya, K Yamamoto, M Mukai, et al. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. DISEASES OF THE COLON & RECTUM. 2002. 45. 1. 98-103

もっと見る

講演・口頭発表等 (102件)：

A novel combination therapy of radiation with cancer vaccine using a mutant HSV for the treatment of colon carcinoma
(Annual Meeting of American Association for Cancer Research 2002)
A novel combination therapy of radiation with cancer vaccine using a mutant HSV for the treatment of colon carcinoma
(Annual Meeting of American Association for Cancer Research 2002)
胃癌の5-fluorouracil感受性におけるnucleoside transporter mRNAの有用性
(第34回制癌剤適応研究会 2001)
COX-2選択的阻害剤(JTE-522)を用いた大腸癌肝転移抑制効果の検討
(第34回制癌剤適応研究会 2001)
大腸癌におけるCOX-2発現-予後を予測するマーカーとしての可能性-
(第34回制癌剤適応研究会 2001)

もっと見る

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM